c-LEcta GmbH
Sebastian Bartsch has a diverse work experience starting from 2006. Sebastian began with an internship at Seramun Diagnostics in Heidesee, Germany, followed by a guest researcher role at KTH, Stockholm, Sweden. After that, they worked as a PhD student at the University of Greifswald. Later, they served as a PostDoc at BioNexGen and Rijksuniversiteit Groningen. Currently, they are working at c-LEcta GmbH and has held various roles, including Project Leader, Team Manager R&D, and currently serves as the Head of Bioinformatics.
Sebastian Bartsch obtained a Diploma in Biochemistry from Ernst-Moritz-Arndt Universität Greifswald between 2002 and 2007. Later, they pursued further education and achieved a Dr. rer. nat. in Biochemistry from Universität Greifswald from 2007 to 2010.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.